๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Thrombocythemia, Essential

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms NCT06063486Phase 22 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles University of Southern California ยท Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Curcumin/ Demethoxycurcumin/Bisdemethoxycurcumin-coโ€ฆ Asian Myeloproliferative Neoplasm (MPN) Registry NCT05882773n/a1 site๐Ÿ“ Hong Kong The University of Hong Kong Study of INCA036978 in Participants With Myeloproliferative Neoplasms NCT07441694Phase 154 sites๐Ÿ“ Birmingham๐Ÿ“ Irvine๐Ÿ“ Los Angeles Incyte Corporation ยท Tests: INCA036978, Standard disease-directed therapy Research Platform Myelofibrosis and Anemia NCT06976918n/a1 site๐Ÿ“ Multiple Locations iOMEDICO AG Myeloproliferative Neoplasms (MPNs) Patient Registry NCT02760238n/a1 site๐Ÿ“ Toronto University Health Network, Toronto ยท Tests: Observational Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF) NCT06327100Phase 1, Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Ruxolitinib, Tasquinimod A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs) NCT06661915Phase 231 sites๐Ÿ“ Irvine๐Ÿ“ Orange๐Ÿ“ Palo Alto National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Decitabine and Cedazuridine, Iadademstat Ruxolitinib in Thrombocythemia and Polycythemia Vera NCT04644211Phase 24 sites๐Ÿ“ Boston๐Ÿ“ Boston๐Ÿ“ Boston Massachusetts General Hospital ยท Tests: Ruxolitinib Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients NCT04655092Phase 36 sites๐Ÿ“ Toon-shi๐Ÿ“ Tsu๐Ÿ“ Suita-shi PharmaEssentia Japan K.K. ยท Tests: P1101 (Ropeginterferon alfa-2b) Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis. NCT05440838n/a6 sites๐Ÿ“ Angers๐Ÿ“ Brest๐Ÿ“ Nantes University Hospital, Angers ยท Tests: Next-generation sequencing Peginterferon ฮฑ-2b Injection for Hydroxyurea Resistant or Intolerant ET NCT06552429Phase 28 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Fujian Xiamen Amoytop Biotech Co., Ltd. ยท Tests: Peginterferon ฮฑ-2b injection, Peginterferon ฮฑ-2b injection Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm NCT07590986n/a1 site๐Ÿ“ Brussels Universitรฉ Catholique de Louvain A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial NCT06786234Phase 214 sites๐Ÿ“ Poitiers๐Ÿ“ Brest๐Ÿ“ Marseille Step Pharma, SAS ยท Tests: STP938 Ropeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis NCT06770842Phase 21 site๐Ÿ“ Hong Kong The University of Hong Kong ยท Tests: Ropeginterferon alfa-2b (BESREMiยฎ) Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms NCT04282187Phase 21 site๐Ÿ“ Seattle University of Washington ยท Tests: Decitabine, Ruxolitinib, Fedratinib, Questionnaire Administration, Pacritinib Therapeutic RSK1 Targeting in Myeloid Malignancies NCT07379125Phase 11 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: PMD-026 Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120) NCT05835466Phase 29 sites๐Ÿ“ Tampa๐Ÿ“ Atlanta๐Ÿ“ Buffalo Icahn School of Medicine at Mount Sinai ยท Tests: reparixin A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i) NCT06343805Phase 121 sites๐Ÿ“ Palo Alto๐Ÿ“ Tampa๐Ÿ“ Kansas City Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lโ€ฆ ยท Tests: LY5830966 A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms NCT07849231Phase 14 sites๐Ÿ“ Liverpool๐Ÿ“ Sydney๐Ÿ“ Melbourne Damora Therapeutics ยท Tests: DMR-001, Ruxolitinib Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia NCT05320198Phase 1, Phase 235 sites๐Ÿ“ Gilbert๐Ÿ“ Duarte๐Ÿ“ Irvine Disc Medicine, Inc ยท Tests: DISC-0974 A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes NCT07203768n/a24 sites๐Ÿ“ Rochester๐Ÿ“ Halle๐Ÿ“ Hanover FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial NCT06541249Phase 21 site๐Ÿ“ New York Icahn School of Medicine at Mount Sinai ยท Tests: Methotrexate (MTX) A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis NCT05714072Phase 17 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Ruxolitinib, Abemaciclib MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) NCT07362225n/a2 sites๐Ÿ“ Chicago๐Ÿ“ New York MPN Research Foundation A Study of GLB-001 in Patients With Myeloid Malignancies NCT06378437Phase 114 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Chongqing Hangzhou GluBio Pharmaceutical Co., Ltd. ยท Tests: GLB-001 A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms NCT06034002Phase 113 sites๐Ÿ“ Duarte๐Ÿ“ Palo Alto๐Ÿ“ Miami Incyte Corporation ยท Tests: INCA033989, Ruxolitinib MPNdpoint. Single-center, Retrospective, Prospective Study of the Outcome of Patients With Philadelphia-negative Chronic Myeloproliferative Neoplasms NCT07863466n/a1 site๐Ÿ“ Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Efficacy and Safety of Peginterferon in ET and PV. NCT06734637NA1 site๐Ÿ“ Wuhan Zhenya Hong ยท Tests: Peginterferon ฮฑ-2b injection AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms NCT05198960Phase 342 sites๐Ÿ“ Angers๐Ÿ“ Annecy๐Ÿ“ Argenteuil University Hospital, Brest ยท Tests: Direct Oral Anticoagulants, Low-dose aspirin Two Step Haplo With Radiation Conditioning NCT05031897Phase 21 site๐Ÿ“ Philadephia Thomas Jefferson University ยท Tests: Fludarabine, Total-Body Irradiation, Donor Lymphocyte Infusion, Cyclophosphamide, Tacrolimus
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy